No association between very low density lipoprotein receptor (VLDL-R) and Alzheimer disease in American Caucasians
β Scribed by M.L. Pritchard; A.M. Saunders; P.C. Gaskell; G.W. Small; P.M. Conneally; B. Rosi; L.H. Yamaoka; A.D. Roses; J.L. Haines; M.A. Pericak-Vance
- Book ID
- 116125645
- Publisher
- Elsevier Science
- Year
- 1996
- Tongue
- English
- Weight
- 316 KB
- Volume
- 209
- Category
- Article
- ISSN
- 0304-3940
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The apolipoprotein (APO) E4 isoform is associated with an accelerated rate of Alzheimer disease (AD) expression in sporadic as well as late-onset familial forms of the disease but the precise mechanism is unknown. In an attempt to approach the possible mechanisms involved, APOE receptors have been s
atrophy (SMA) type I1 and 111 in the same sibship are not caused by different alleles at the SMA locus on 5q. Am J Hum
## Abstract A number of studies suggest that brain cholesterol metabolism may play a role in Alzheimer's disease (AD) development, probably through modulation of amyloid beta production. The discovery that apolipoprotein E (__APOE__) Ξ΅4 allele is a risk factor for sporadic AD raises the possibility